Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1991 Mar;66(3):341–343. doi: 10.1136/adc.66.3.341

Tolerance to somatostatin analogue in a preterm infant with islet cell dysregulation syndrome.

J M Hawdon 1, M P Ward Platt 1, W H Lamb 1, A Aynsley-Green 1
PMCID: PMC1792864  PMID: 2025013

Abstract

An infant of 31 weeks' gestation presented with refractory neonatal hypoglycaemia secondary to islet cell dysregulation. Treatment was started with somatostatin analogue and his glycaemic control improved initially. Tolerance developed, however, in that the dose required to maintain control increased by a factor of 40. The infant subsequently underwent pancreatectomy. It is safe to use somatostatin analogue in a preterm infant, but tolerance to the drug rapidly develops.

Full text

PDF
342

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aynsley-Green A., Barnes N. D., Adrian T. E., Kingston J., Boyes S., Bloom S. R. Effect of somatostatin infusion on intermediary metabolism and entero-insular hormone release in infants with hyperinsulinaemic hypoglycaemia. Acta Paediatr Scand. 1981 Nov;70(6):889–895. doi: 10.1111/j.1651-2227.1981.tb06246.x. [DOI] [PubMed] [Google Scholar]
  2. Bougnères P. F., Landier F., Garnier P., Job J. C., Chaussain J. L. Treatment of insulin excess by continuous subcutaneous infusion of somatostatin and glucagon in an infant. J Pediatr. 1985 May;106(5):792–794. doi: 10.1016/s0022-3476(85)80358-9. [DOI] [PubMed] [Google Scholar]
  3. Hirsch H. J., Loo S., Evans N., Crigler J. F., Filler R. M., Gabbay K. H. Hypoglycemia of infancy and nesidioblastosis. Studies with somatostatin. N Engl J Med. 1977 Jun 9;296(23):1323–1326. doi: 10.1056/NEJM197706092962305. [DOI] [PubMed] [Google Scholar]
  4. Jackson J. A., Hahn H. B., Jr, Oltorf C. E., O'Dorisio T. M., Vinik A. I. Long-term treatment of refractory neonatal hypoglycemia with long-acting somatostatin analog. J Pediatr. 1987 Oct;111(4):548–551. doi: 10.1016/s0022-3476(87)80118-x. [DOI] [PubMed] [Google Scholar]
  5. Kitson H. F., McCrossin R. B., Jimenez M., Middleton A., Silink M. Somatostatin treatment of insulin excess due to beta-cell adenoma in a neonate. J Pediatr. 1980 Jan;96(1):145–151. doi: 10.1016/s0022-3476(80)80353-2. [DOI] [PubMed] [Google Scholar]
  6. Wilson D. C., Carson D. J., Quinn R. J. Long-term use of somatostatin analogue SMS 201-995 in the treatment of hypoglycaemia due to nesidioblastosis. Acta Paediatr Scand. 1988 May;77(3):467–470. doi: 10.1111/j.1651-2227.1988.tb10683.x. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES